GNRH1 and prostate carcinoma: Can be used as monotherapy at higher dosageUsed for treatment of metastatic (stage D2) prostate cancer, together with a luteinizing hormone releasing hormone (LHRH) analog or surgical removal of the testicles to treat advanced prostate cancer